Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Gout is a crystal arthropathy caused by monosodium urate (MSU) crystal deposition in joints from elevated serum uric acid. The classic gout attack presents as sudden, severe pain — often waking the patient at 2–4 AM — in the first metatarsophalangeal joint (big toe), but gout can affect the ankle, midfoot, knee, and other joints. Gout is eminently treatable with the right acute management and long-term urate-lowering therapy. Dr. Tom Biernacki, DPM at Balance Foot & Ankle in Howell and Bloomfield Hills, Michigan diagnoses and manages gout attacks and coordinates ongoing urate control with primary care.

Why Gout Attacks the Big Toe First

Gout preferentially deposits urate crystals in the first metatarsophalangeal (MTP) joint for several reasons: this joint is the coolest peripheral joint in the body (lower temperature promotes urate crystallization), it undergoes significant mechanical stress with every step (promoting crystal shedding), and the first MTP is among the most distal joints with reduced circulation for crystal clearance. The resulting condition — podagra — was historically called “the disease of kings” due to its association with purine-rich diet and alcohol. Today it affects approximately 8 million Americans regardless of socioeconomic status, with rates increasing due to rising obesity, chronic kidney disease, and diuretic use.

Recognizing a Gout Attack

The acute gout attack is one of the most painful conditions in medicine. Characteristic features: sudden onset — often waking the patient at night — of severe joint pain, dramatic swelling and redness (the joint may appear purple), warmth over the affected joint measurable at a distance, exquisite tenderness where even the weight of a bedsheet is intolerable, and systemic features including low-grade fever in severe attacks. The big toe MTP is the classic site, but gout attacks the ankle (in approximately 50% of patients at some point), the midfoot (Lisfranc area), the knee, and less commonly the wrist and elbow. First attacks resolve spontaneously within 7–14 days even without treatment.

Diagnosis

The gold standard for gout diagnosis is joint aspiration with polarized light microscopy — needle-shaped monosodium urate crystals with negative birefringence are pathognomonic. In practice, a classic clinical presentation (sudden big toe pain, hyperuricemia, rapid response to colchicine) often allows clinical diagnosis without aspiration. Serum uric acid is elevated above 6.8 mg/dL in hyperuricemia, but can be NORMAL during an acute attack (acute inflammation redistributes urate) — a normal uric acid during an attack does not rule out gout. X-rays may show punched-out erosions with overhanging edges (“rat bite” erosions) in chronic gout; joint space is typically preserved unlike osteoarthritis. Musculoskeletal ultrasound can identify the “double contour” sign of urate crystal deposition on cartilage — increasingly used as a non-invasive diagnostic tool.

Acute Attack Treatment

Three first-line options for acute gout: NSAIDs (indomethacin 50mg TID or naproxen 500mg BID for 5–7 days) — most effective when started within the first 24 hours; colchicine (1.2mg initially then 0.6mg one hour later, followed by 0.6mg BID until attack resolves) — highly effective and better tolerated than high-dose NSAIDs; and corticosteroids (prednisone 30–35mg/day tapered over 5 days, or intra-articular injection) — appropriate when NSAIDs and colchicine are contraindicated (renal disease, drug interactions). Ice to the joint reduces inflammation and provides additional pain relief. Elevation and offloading with a surgical shoe or walking boot significantly improves comfort during the attack. Start urate-lowering therapy only AFTER the acute attack resolves — starting allopurinol during an attack prolongs flare duration.

Long-Term Urate-Lowering Therapy

The goal of long-term management is maintaining serum uric acid below 6 mg/dL (below 5 mg/dL in tophaceous gout). Allopurinol is the most commonly used urate-lowering agent — started at 100mg/day and titrated up to achieve target serum levels, with most patients requiring 300–600mg/day. Febuxostat is an alternative for allopurinol-intolerant patients. Probenecid (a uricosuric) is an option for patients who under-excrete rather than over-produce uric acid. Diet modification reduces uric acid modestly: reduce red meat, shellfish, alcohol (particularly beer and spirits), and fructose-sweetened beverages; increase low-fat dairy, cherry consumption (shown in studies to reduce gout attacks), and water intake. Dietary modification alone rarely achieves target uric acid levels in established gout.

Most Common Mistake in Gout Management

The most common mistake is treating acute attacks without initiating long-term urate-lowering therapy. Each gout attack causes joint damage and increases the risk of subsequent attacks. Patients who treat attacks episodically but maintain persistently elevated uric acid develop tophaceous gout (crystal deposits in soft tissue), permanent joint damage, and chronic kidney disease from urate nephropathy. The correct approach: treat the acute attack effectively, then begin urate-lowering therapy after the attack resolves with a target serum uric acid below 6 mg/dL, maintained indefinitely.

When to See a Podiatrist for Gout

See a podiatrist for any sudden, severe foot or ankle joint pain with swelling and redness — especially if it begins at night. Dr. Biernacki provides in-office joint aspiration for diagnostic confirmation when needed, acute attack treatment including intra-articular corticosteroid injection, offloading with a surgical shoe or walking boot during the attack, and coordination with primary care for long-term urate-lowering therapy. Patients with recurrent gout affecting the feet benefit from podiatric monitoring for joint damage, tophi, and secondary flatfoot from chronic joint inflammation. Book same-day online or call (810) 206-1402 — Howell and Bloomfield Hills, Michigan.

Gout Treatment in Michigan

Gout attacks in the foot and ankle are excruciatingly painful and require expert management. Our podiatrists provide acute gout treatment, long-term urate management, and monitoring to prevent joint destruction and recurrence.

Learn About Our Foot & Ankle Treatments → | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Dalbeth N, et al. “Gout.” Lancet. 2016;388(10055):2039-2052.
2. FitzGerald JD, et al. “2020 American College of Rheumatology guideline for management of gout.” Arthritis Care & Research. 2020;72(6):744-760.
3. Khanna D, et al. “2012 ACR guidelines for management of gout.” Arthritis Care & Research. 2012;64(10):1431-1446.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.